We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Propeller Health

News List

Connected drug delivery devices market to grow to $4bn by 2028 europeanpharmaceuticalreview
March 04, 2021
A new report reveals the COVID-19 pandemic, prevalence of chronic disease and increasing patient engagement will all drive adoption of connected drug delivery devices.
Propeller Health announces My Pharmacy, enabling in-app pharmacy experience for patients with asthma and COPD firstwordpharm
January 10, 2019
Propeller Health, a leading digital therapeutics company, today announced My Pharmacy, connecting Propeller users living with asthma and chronic obstructive pulmonary disease (COPD) directly to pharmacy services in the Propeller mobile app.
ResMed to acquire connected inhaler developer Propeller Health for $225M fiercebiotech
January 03, 2019
Former Fierce 15 winner Propeller Health is being acquired by ResMed in a $225 million deal that aims to broaden the reach of its connected respiratory devices to patients across all stages of chronic obstructive pulmonary disease (COPD).....
Aptar Pharma and Propeller Health partner to develop digital medicine platform across therapeutic areas europeanpharmaceuticalreview
June 01, 2018
Collaboration also includes strategic investment by Aptar Pharma; will add connectivity to drug-delivery routes to improve adherence and treatment outcomes…